echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The Upstream and Downstream products of N-[4-(1-Cyanocyclopentyl)phenyl]-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide methanesulfonate

    The Upstream and Downstream products of N-[4-(1-Cyanocyclopentyl)phenyl]-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide methanesulfonate

    • Last Update: 2023-04-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The chemical compound N-[4-(1-Cyanocyclopentyl)phenyl]-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide methanesulfonate, also known as MK-8628, is a novel and promising molecule in the field of pharmaceuticals and drug discovery.
    This compound has been shown to exhibit potent and selective activity against certain disease targets, making it a valuable tool for the development of new therapies.


    One key aspect of the chemical industry is the identification and development of new active pharmaceutical ingredients (APIs), which are the molecules that have therapeutic effects and are used in drugs.
    MK-8628 is an example of an upstream product in this process, as it is a molecule that has been synthesized and characterized as a potential API.


    Downstream from MK-8628, the compound can be further processed and transformed into a variety of different products.
    One such product is a salt form of the compound, such as the methanesulfonate salt.
    This salt form has different physical and chemical properties than the parent compound, and it may have different pharmacokinetic and pharmacodynamic properties as well.
    Salt forms of APIs are commonly used in the pharmaceutical industry because they can improve the stability, solubility, and bioavailability of the API.


    Another product that can be derived from MK-8628 is a prodrug, which is a molecule that is converted to the active form of the drug in the body.
    Prodrugs are often used to improve the pharmacokinetic and pharmacodynamic properties of APIs by modifying their chemical structure or properties.
    For example, a prodrug of MK-8628 could be designed to have improved oral bioavailability, longer half-life, or targeted delivery to specific tissues or cells.


    In addition to drugs, MK-8628 and its derivatives can also be used in various other applications in the chemical industry.
    For example, the compound may be used as a building block or starting point for the synthesis of other molecules, such as intermediates or other APIs.
    MK-8628 may also be used as a research tool or reagent in various laboratory settings, such as in the study of biochemical pathways or the development of new assays or diagnostic tests.


    Overall, the compound MK-8628 and its derivatives represent an important and promising tool for the development of new therapies and products in the chemical industry.
    The upstream and downstream products derived from this compound can be used in a variety of applications and can help to advance our understanding of the underlying biology and chemistry of disease and drug action.
    With continued research and development, MK-8628 and its derivatives may ultimately lead to the discovery of new and effective treatments for a range of diseases.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.